With all the talk about COVID-19 vaccines, the people producing them might be forgotten. But what if they were in your own state? Omaha Clinical Research has paved the way for safe COVID-19 vaccination and gained national recognition. QCR conducts trials with pharmaceutical drugs such as Madrna and Pfizer, two of the leading coronavirus vaccines.
The analysis of the trials has led to countless lives being saved. When asked what makes QCR stand out above the rest, Research Coordinator Nia Shannon said she believes the number of participants in the trial was imperative to its success.
“I think what sets us ahead is we are one of the few research companies here in Omaha and being one of the few we also worked closely with Pfizer on the COVID-19 vaccine trial, and they are one of the top, leading pharmaceutical companies doing the COVID-19. So, I think that being we had over 200 people in our vaccine trial it really put the spotlight on us,” Nia said.
The Trial was conducted with over 200 diverse participants, half of those participants received the COVID-19 vaccine and the other received a placebo. This was a paid study that had to meet certain criteria’s, and serval screenings before being accepted. When accepted for the trials the participant received their shot in their non-dominate arm while looking in the opposite side to prevents the participant from seeing if it is the vaccine or placebo. Once the shot is administrated the participant would wait for 30 minutes and after that period, they are free to go with money on the way. QCR is behind the research of phase I through phase IV for pharmaceutical companies. With 25 staff members Quality Clinical Research conducted the large study with high praise from pharmaceutical companies.
As Americans start to see the end of the pandemic, we still have over thousands of people infected with COVID-19. Though the success of the trials has saved lives, QRC’s Vice President Seneca Harrison stress the work is not done yet. Harrison also recommends everyone still adhere to the CDC guidelines.
“It’s exciting to be a part of but, we need more people to volunteer, we need more people to get involved and get people to testing sites,” Harrison said.
